Fibroblast growth factor 23 actions in inflammation: a key factor in CKD outcomes

Inflammation regulates fibroblast growth factor 23 production

(2016) Connor Francis et al.   CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION

The role of fibroblast growth factor 23 and Klotho in uremic cardiomyopathy

(2016) Alexander Grabner et al.   CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION

Intact FGF23 and α-klotho during acute inflammation/sepsis in CKD patients

(2016) Evangelia Dounousi et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

FGF23 signaling impairs neutrophil recruitment and host defense during CKD

(2016) Jan Rossaint et al.   JOURNAL OF CLINICAL INVESTIGATION

Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production

(2016) Valentin David et al.   KIDNEY INTERNATIONAL

Update on Inflammation in Chronic Kidney Disease

(2015) Oleh M. Akchurin et al.   BLOOD PURIFICATION

Platelets in leucocyte recruitment and function

(2015) Jan Rossaint et al.   CARDIOVASCULAR RESEARCH

Activation of Cardiac Fibroblast Growth Factor Receptor 4 Causes Left Ventricular Hypertrophy

(2015) Alexander Grabner et al.   Cell Metabolism

HIF Hydroxylase Pathways in Cardiovascular Physiology and Medicine

(2015) T. Bishop et al.   CIRCULATION RESEARCH

Inflammation but not obesity or insulin resistance is associated with increased plasma fibroblast growth factor 23 concentration in the elderly

(2015) Michał Holecki et al.   CLINICAL ENDOCRINOLOGY

Cause of Death in Patients with Reduced Kidney Function

(2015) S. Thompson et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Low Vitamin D and High Fibroblast Growth Factor 23 Serum Levels Associate with Infectious and Cardiac Deaths in the HEMO Study

(2015) M. Chonchol et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Regulation of FGF23 expression in IDG-SW3 osteocytes and human bone by pro-inflammatory stimuli

(2015) Nobuaki Ito et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Calcium Regulates FGF-23 Expression in Bone

(2013) Valentin David et al.   ENDOCRINOLOGY

Effects of iron deficiency anemia and its treatment on fibroblast growth factor 23 and phosphate homeostasis in women

(2013) Myles Wolf et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Neonatal Iron Deficiency Causes Abnormal Phosphate Metabolism by Elevating FGF23 in Normal and ADHR Mice

(2013) Erica L Clinkenbeard et al.   JOURNAL OF BONE AND MINERAL RESEARCH

The iron cycle in chronic kidney disease (CKD): from genetics and experimental models to CKD patients

(2013) K. Zumbrennen-Bullough et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Fibroblast growth factor-23: what we know, what we don't know, and what we need to know

(2013) C. P. Kovesdy et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Prevalence and severity of oral disease in adults with chronic kidney disease: a systematic review of observational studies

(2013) Marinella Ruospo et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Uremia Suppresses Immune Signal-Induced CYP27B1 Expression in Human Monocytes

(2012) Liesbeth Viaene et al.   AMERICAN JOURNAL OF NEPHROLOGY

Association between Albuminuria, Kidney Function, and Inflammatory Biomarker Profile in CKD in CRIC

(2012) J. Gupta et al.   Clinical Journal of the American Society of Nephrology

Fibroblast Growth Factor 23 and Inflammation in CKD

(2012) J. Munoz Mendoza et al.   Clinical Journal of the American Society of Nephrology

Fibroblast growth factor 23 inhibits extrarenal synthesis of 1,25-dihydroxyvitamin D in human monocytes

(2012) Justine Bacchetta et al.   JOURNAL OF BONE AND MINERAL RESEARCH

FGF23 neutralization improves chronic kidney disease–associated hyperparathyroidism yet increases mortality

(2012) Victoria Shalhoub et al.   JOURNAL OF CLINICAL INVESTIGATION

Update on fibroblast growth factor 23 in chronic kidney disease

(2012) Myles Wolf   KIDNEY INTERNATIONAL

Regulation and Function of the FGF23/Klotho Endocrine Pathways

(2012) Aline Martin et al.   PHYSIOLOGICAL REVIEWS

A Comparative Transcriptome Analysis Identifying FGF23 Regulated Genes in the Kidney of a Mouse CKD Model

(2012) Bing Dai et al.   PLoS One

Preventing and Treating Inflammation: Role of Dialysis Access Management

(2012) George M. Nassar   SEMINARS IN DIALYSIS

Adenosine and Hypoxia-Inducible Factor Signaling in Intestinal Injury and Recovery

(2011) Sean P. Colgan et al.   Annual Review of Physiology

Endothelial dysfunction, inflammation and atherosclerosis in chronic kidney disease – a cross-sectional study of predialysis, dialysis and kidney-transplantation patients

(2011) Alejandro Recio-Mayoral et al.   ATHEROSCLEROSIS

Fibroblast Growth Factor 23 and Risks of Mortality and End-Stage Renal Disease in Patients With Chronic Kidney Disease

(2011) Tamara Isakova   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Longitudinal evaluation of FGF23 changes and mineral metabolism abnormalities in a mouse model of chronic kidney disease

(2011) Jason R Stubbs et al.   JOURNAL OF BONE AND MINERAL RESEARCH

FGF23 induces left ventricular hypertrophy

(2011) Christian Faul et al.   JOURNAL OF CLINICAL INVESTIGATION

Direct and indirect effects of parathyroid hormone on circulating levels of fibroblast growth factor 23 in vivo

(2011) Ignacio López et al.   KIDNEY INTERNATIONAL

Acute loss of renal function attenuates slow leukocyte rolling and transmigration by interfering with intracellular signaling

(2011) Jan Rossaint et al.   KIDNEY INTERNATIONAL

Markers of inflammation predict the long-term risk of developing chronic kidney disease: a population-based cohort study

(2011) Anoop Shankar et al.   KIDNEY INTERNATIONAL

Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease

(2011) Tamara Isakova et al.   KIDNEY INTERNATIONAL

Chronic kidney disease

(2011) Andrew S Levey et al.   LANCET

The neutrophil in vascular inflammation

(2011) Mia Phillipson et al.   NATURE MEDICINE

Tumor Necrosis Factor and Interferon-γ Down-regulate Klotho in Mice With Colitis

(2009) Robert D. Thurston et al.   GASTROENTEROLOGY

Circulating Fibroblast Growth Factor 23 in Patients with End-Stage Renal Disease Treated by Peritoneal Dialysis Is Intact and Biologically Active

(2009) Takashi Shimada et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Cytokine patterns and survival in haemodialysis patients

(2009) S. D. Cohen et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

NF-κB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1α

(2008) Jordi Rius et al.   NATURE

Fibroblast Growth Factor 23 and Mortality among Patients Undergoing Hemodialysis

(2008) Orlando M. Gutiérrez et al.   NEW ENGLAND JOURNAL OF MEDICINE

Arrest Chemokines

(2003) KLAUS LEY   MICROCIRCULATION